Education Committee

Dr. Susanna Galea-Singer and vacancy (Co-Chairs)

The purpose of the Training and Education committees is to increase and improve the capability and capacity of addiction medicine training and educational activities. Training activities will largely seek to address training needs of addiction specialists (including postgraduate training needs). Education activities will largely seek to address education needs of those either working within the field of addiction who are not addiction specialists (including undergraduate medical students and trainee doctors) or those working in other fields looking to increase their knowledge, skill and confidence in addiction medicine.


This will be accomplished through a number of activities that will be determined through a shared education and training strategy, including:

  • Training and education workshops and symposia at the annual ISAM Conference
  • Scoping activities to identify areas of training and education need internationally, through surveys of the ISAM global membership and consensus-based prioritization
  • Development of training and education modules or packages to be delivered in response to areas of need
  • Joint work in collaboration with international ISAM affiliate organisations to deliver training and education activities in response to local areas of need


Dr. Susanna Galea-Singer (New Zealand)

Co-Chair vacancy


ISAM Education and Training committee members

Communication Committee

Dr. Helena Hansen and Dr. Marica Ferri (Co-Chairs)

The purpose of this committee is to increase and improve the communication capability and capacity of the International Society of Addiction Medicine (ISAM) to its members (individual and affiliate societies).

This committee will be composed of individuals working in the field of addiction interested and or specialists in the fields of clinical delivery and leadership, quality improvement, healthcare systems innovation, clinical governance and precision/personalised medicine and are additionally able to utilise effectively different communication platforms.


This will be accomplished through:

  • Fortnightly executive summaries to all ISAM members
  • Regular communication that is of specific value to either ISAM individual members and/or ISAM affiliate societies
  • Maximise the Twitter, Linkidn and other social media handles
  • Regularly sustain the news feeds within the ISAM website



Dr. Helena Hansen (USA)

Professor and Chair
Research Theme in Translational Social Science and Health Equity
David Geffen School of Medicine at UCLA


Dr. Marica Ferri (Portugal)
Head of Sector – Support to Practice
Public Health Unit
European Monitoring Centre for Drugs and Drug Addiction – EMCDDA
Lisbon, Portugal


Committee members:

Regional Council Updates
Dr. Tomohiro Shirasaka (Japan)
Director, Department of Psychiatry, Teine Keijinkai Medical Center.
E-mail :


Visual Communications
Dr Joe Tay Wee Teck (UK)
Clinical Director, Forward Leeds
Honorary Research Fellow, School of Medicine
St Andrews University, Scotland


Twitter and LinkedIn
Hossein Mohaddes Ardabili (Iran)
Psychiatry resident
Psychiatry and Behavioral Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine,
Mashhad University of Medical Sciences, Mashhad, Iran.


Website updates
Sarah Namirembe (Uganda)
Student , Medical Anthropology


Newsletter Liaison
Prof Fatima El Omari  (Morocco)
Professor of Psychiatry
Head of Addiction, University Center at Arrazi Psychiatric University Hospital of Rabat-Salé
Faculty of Medicine, University Mohammed Vth of Rabat- Morocco

Finance Committee and External Funding

Dr. Yasser Khazaal, Treasurer (Chair)

The ISAM Finance & External Funding Committee will seek opportunities to develop new revenue streams for ISAM and bring these opportunities to the ISAM Board for approval/further development


PROPOSED ISAM Conflict of Interest Policies

General Firewalls:

  • Companies must apply to ISAM for participating corporation status (See Below). In this application the company must demonstrate their interest in and commitment to the mission of ISAM
  • Grants from companies must be unencumbered of obligation to the sponsor, support legitimate scientific or educational purposes, be based on objective criteria, and must not represent payment for influence or favorable treatment.
  • Grants are only accepted by ISAM in support of programs that are designed to be of benefit to the field and are independently managed by members of the ISAM.  Grants are only accepted from companies that have been approved as participating corporations.
  • All grants are publicly disclosed on the ISAM website. All funds received from grants are used for the purpose designated in the grant. Any funds that may remain from those grants are reported on our annual audited financial statement, are carried over and used for that purpose in subsequent years, or are returned to the granting company.
  • The ISAM Executive Office staff handles all financial matters with participating corporations, i.e. collecting fees and making grant requests.  Staff members have no vote on any official ISAM program activities.  The ISAM members who participate in those official College activities are not involved in financial matters and often are not aware of the financial contributions that may or may not have been made by any company.
  • All members of key ISAM bodies, such as the Board of Directors, are required to fully disclose all potential conflicts of interest at least annually


  • Annual Meeting Firewalls:
  • All participating corporations are treated the same.  Each is offered the same opportunity to support the meeting and each is acknowledged and recognized in meeting materials based on the amount of grant support provided. No specific sessions are identified as having been sponsored by a certain company. No support is accepted from any company that has not been approved by the ISAM Board as a participating corporation.
  • Participating corporations are not allowed to sponsor social activities, satellite sessions, or other events that take meeting attendees away from the meeting site.
  • The activities of participating corporations at the Annual Meeting are monitored by asking all meeting attendees to report on the meeting evaluation any activity that they believed to be inappropriate.


Membership Committee

Dr. Atul Ambekar, Chair

The purpose of the committee is to maintain and increase the membership in the society.


This will be accomplished through:

  • Updating the criteria for membership in the society.
  • Assessing the qualifications of membership applicants.
  • Issuing membership certificates.
  • Promoting campaigns to maintain and increase membership in the society.



  • The committee will consist of a Chair and a maximum of 10
  • The Chair and members must be ISAM members.
  • The Chair will be nominated by the president, subject to Board approval.
  • Members will be nominated by the Chair, subject to Board approval.
  • The Chair and members should ideally represent different global regions.
  • The membership term will be three years.


The 2021 Categories of membership are:

ISAM Medical Practitioners member

ISAM Non-Medical Practitioners members

ISAM undergraduate students

ISAM Clinical and Non-Clinical Scientists  

ISAM-NEXT members

Honorary/Emeritus ISAM Members

Retired ISAM Members

NExT Committee (New professionals Exploration, Training and Education)

Dr. Roshan Bhad (Chair)

The purpose of the committee is to increase and improve the capability and capacity of addiction medicine training and other educational activities. The name of the committee will be ISAM-NEXT with pre-defined role of Exploration (Opportunities and Research), Training & Education for new professionals in the field.



  • To mentor (mentor-mentee activities) early career addiction medicine professionals for specific issues in research, training (e.g. leadership/trainer of trainers), clinical practice as well as career progression to mid-level career
  • To emphasize on supporting this community of young addiction medicine professionals and promote liaison and communication between early career addiction medicine specialists of different countries
  • To promote participation of early career addiction medicine professionals in various scientific meetings by offering fellowship or funding, organization of special symposia for this community
  • To promote evidence and competency based medical education in the field of addiction medicine
  • To encourage and motivate graduate health professionals to take


The ISAM NExt Committee has six sub-committies:

  1. Training and education
  2. Publications
  3. Mentorship, Scholarships and Job Opportunities
  4. Social Media and Communications
  5. International Collaboration and Newtorking
  6. Gender and Diversity in Addiction Medicine



Dr. Roshan Bhad (India)
Assistant Professor,
National Drug Dependence Treatment Centre (NDDTC),
AIIMS, New Delhi


Dr. Sophie Achab (Switzerland)
Medical Associate Deputy
(University Hospitals of Geneva),
WHO Collaborating Center for Training and Research in Mental Health,
Board member of ISSBA


Dr. Hossein Mohaddes Ardabili (Iran)
Psychiatric Assistant,
Mashhad University of Medical Sciences,
Mashhad, Iran


Committee Secretary:

Dr. Preethy Kathiresan, M.B.B.S., M.D., D.N.B., D.M. Addiction Psychiatry,

International Certification in Addiction Medicine,
Assistant Professor (Psychiatry),
AIIMS Jodhpur



Publications Committee

Dr. Marc Potenza (Chair)

  • Promote and ensure liaison with publication and member participation in submissions for publication



Dr. Marc Potenza (USA)
Director, Division on Addiction Research, Yale University
Director, Yale Center of Excellence in Gambling Research
Director, Women and Addictions Core of Women’s Health research, Yale
Director, Yale Impulsivity Research Program
Professor, Psychiatry, Neuroscience and Child Study, Yale School of Medicine



Dr. Geert Dom (Belgium)
Professor of Psychiatry, University of Antwerp
Medical Director, PC Multiversum, Boechout, Belgium
President, European Federaton of Addiction Socieites (EUFAS)
President, Belgian Professional Society of Medical Specialists in Psychiatry



Committee Members Include Co-Chairs Geert Dom (Belgium) and Marc Potenza (USA) and Other Members (Philippe De Timary (Belgium), Hamed Ekhtiari (USA), Nady el-Guebaly (Canada), Hussein Elkholy (Egypt/Scotland; ISAM NeXT member), Eva Hoch (Germany), Susana Jiminez-Murcia (Spain), Dan Lubman (Australia), Icro Maremmani (Italy), Ismene Petrakis (USA), Arnt Schellekens (Netherlands)

2021 Publication Committee Activities Report

  • Published ISAM/CSAM 2020 Joint Conference Overview, Selected Abstracts with Nady el-Guebaly in Substance Abuse journal
  • Published ISAM/CSAM 2020 Conference Selected Abstracts in Canadian Journal of Addictions
  • Additional ISAM Publication Efforts in Frontiers in Psychiatry (Global Surveys), BJPsych International (Including Work by ISAM NeXT), Substance Abuse journal (Spirituality Interest Group Position Paper), and Lancet Psychiatry (Displaced Populations)
  • Working with ISAM GEN to Follow Up on World Surveys
  • Discontinuing Contract with Substance Abuse journal
  • Exploring Editorial Publication with Selected Abstracts in Drug and Alcohol Dependence, Closer Collaborative Work with the College on Problems of Drug Dependence
  • Drs. Alex Baldacchino, Joe Tay Wee Tack and Susanna Galea-Singer are preparing a section on international policy for the journal Current Addiction Reports.
  • Drs. Alex Baldacchino, Hussien Elkholy and Marc Potenza are in discussions with BJPsych International for sets of three articles on the topics of Policy and Public Health and Culture and Internationalisation of Addictions and with Lancet Psychiatry on a piece on humanitarian situation and substance misuse.
  • Joe Tay & Alex Baldacchino (2022). Editorial: Why Do Different Forms of Knowledge Matter in Evidence-Based Drug Policy? American Journal in Public Health (AJPH).
  • Patrice Forget, Champika Patullo , Duncan Hill , Atul Ambekar , Alex Baldacchino, Juan Cata , Sean Chetty, Felicia J. Cox, Hans D. de Boer, Kieran Dinwoodie, Geert Dom, Christopher Eccleston, Brona Fullen, Liisa Jutila, Roger D. Knaggs, Patricia Lavand’homme, Nicholas Levy, Dileep N. Lobo, Esther Pogatzki‑Zahn, Norbert Scherbaum, Blair H. Smith, Joop van Griensven and Steve Gilbert (2022). System-level policies on appropriate opioid use. A multi-stakeholder consensus. MDPI Health Service Research 22(1):329. doi: 10.1186/s12913-022-07696-x.
  • Venkata Lakshmi Narasimha, Jenna Butner, Enjeline Hanafi,  Mehdi Farokhnia, Roshan Bhad, Fatemeh Chalabianloo, Christos Kouimtsidis, Alexander Baldacchino and Shalini Arunogiri  (2022). Harm reduction and abstinence-based models for treatment of substance use disorders during COVID-19 pandemic: A global perspective. British Journal of Psychiatry International (BJPsychInt)
  • Hossein Mohaddes Ardabili, Abolfazl Akbari, Parnian Rafei, Jenna Butner, Riaz Khan, Yasser Khazaal, Abdulmalik Zuhair Arab, Mohammed Rafiq Qazizada, Basma Al-Ansari, Alexander Mario Baldacchino (2021). Tramadol, Captagon, and Khat Use in the Eastern Mediterranean Region: Opening Pandora’s Box. British Journal of Psychiatry International (BJPsychInt) doi: 10.1192/bji.2021.53.
  • Tara Rezapour, Javad Hatami, Ali Farhoudian, Alireza Noroozi, Reza Daneshmand, Mehmet Sofuoglu, Alex Baldacchino, Hamed Ekhtiari (2021). Baseline executive functions and receiving cognitive rehabilitation can predict treatment response in people with opioid use disorder. Journal of Substance Abuse Treatment doi:10.1016/j.jsat.2021.108558.
  • Ali Farhoudian, Ramin Radfar, Hossein Mohaddes Ardabili, Parnian Rafei, Mohsen Ebrahim, Arash Khojasteh Zonoozi, Cornelis A J De Jong, Mehrnoosh Vahidi, Masud Yunesian, Anja Busse, Elizabeth Saenz, Giovanna Campello, Kamran Niaz, Christos Kouimtsidis, Shalini Arunogiri, Kathleen T Brady, Marc N Potenza, ISAM-PPIG Global Survey Consortium*,  Alexander Mario Baldacchino, Hamed Ekhtiari (2021) Global survey on changes in the supply, price and pattern of use of illicit drugs and alcohol and related complications during the 2020 COVID-19 pandemic period. Frontiers in Psychiatry doi: 10.3389/fpsyt.2021.646206
  • Seyed Ramin Radfar, Cornelis A. De Jong, Ali Farhoudian, Mohsen Ebrahimi, Parnian Rafei, Mehrnoosh Vahidi, Masud Yunesian, Christos Kouimtsidis, Shalini Arunogiri, Omid Massah, Abbas Deylamizadeh, Kathleen T. Brady, Anja Busse, Marc N. Potenza, Hamed Ekhtiari, Alexander. M. Baldacchino (2021) Reorganization of Substance Use Treatment and Harm Reduction Services during the COVID-19 Pandemic: A Global Survey. Frontiers in Psychiatry doi:10.3389/fpsyt.2021.639393.
  • Koumstididtis, C., Pauly, B., Parkes, T., Stockwell ,T., Baldacchino, A (2021). COVID-19 social restrictions: an opportunity to re-visit the concept of harm reduction in the treatment of alcohol dependence. Frontiers in Psychology doi:10.3389/fpsyt.2021.623649.
  • Forget, P., Baldacchino, A (2021). Substance abuse by anaesthesiologists: shouldn’t we do more? European Journal of Anaesthesiology 38(7); 682-683.doi: 10.1097/EJA.0000000000001466.
  • Qurishi, R., Buwalda, VJA., Drenth JPH., Baldacchino A., Broers B.,De Jong CAJ (2021). An international consultation on case reports in addiction medicine. Substance Abuse Journal 42(4)472-482.
  • Hamed Ekhtiari, Antonio Verdejo-García, Scott J. Moeller, Mehran Zare-Bidoky, Alexander M. Baldacchino, Martin P. Paulus (2020). Brain and Cognition for Addiction Medicine: From Prevention to Recovery. Frontiers in Neuroscience doi: 10.3389/fpsyt.2020.590030.
  • Alexander Baldacchino , Seyed Ramin Radfar , Cornelis De Jong , Parnian Rafei , Masud Yunesian , Gilberto Gerra, Kath­leen Brady, Mohsen Ebrahimi , Mehrnoosh Vahidi , Arash Khojasteh Zonoozi , Hossein Mohaddes Ardabili , Anja Busse, Elizabeth Saenz, Giovanna Campello, Kamran Niaz , Hamed Ekhtiari, Ali Farhoudian (2020). COVID-19 and Substance Use Disorder: Study Protocol for the International Society of Addiction Medicine Practice and Policy Interest Group Global Survey. Basic and Clinical Neuroscience doi:10.32598/bcn.11.covid19.2545.1.
  • Cor A. J. DeJong, Janine G. DeJong Verhagen, Robert Pols,Cor A.G. Verbrugge, Alexander Baldacchino (2020). Psychological impact of the acute COVID-19 period on patients with substance use disorders (SUD): We are all in it together. Basic and Clinical Neuroscience 163-172.
  • Ali Farhoudian , Alexander Baldacchino, Nicolas Clark, Gilberto Gerra, Hamed Ekhtiari, Geert Dom, Azarakhsh Mokri,  Mandana Sadeghi, Pardis Nematollahi, Maryanne Demasi, Christian G. Schütz, Seyed Mohammadreza Hashemian, Payam Tabarsi, Susanna Galea-Singer, Giuseppe Carrà, Thomas Clausen, Christos Kouimtsidis, Serenella Tolomeo, Seyed Ramin Radfar, Emran Mohammad Razaghi (2020). COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper Basic and Clinical Neuroscience  129-145.
  • Antonio Verdejo-Garcia, Hamed Ekhtiari, Valentina Lorenzetti, Victoria Manning, David Pennington, Shalini Arunogiri, Marsha Bates, Raimondo Bruno, Salvatore Campanella, Stacey Daughters, Rob Hester, Christos Kouimtsidis, Dan Lubman, Dieter Meyerhoff, Scott Moeller, Martin Paulus, Tara Rezapour, Serenella Tolomeo, Alex Baldacchino, Hamed Ekthiari  (2019) A roadmap for integrating neuroscience into addiction treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine. Frontiers in Psychiatry 10:877.  doi: 10.3389/fpsyt.2019.00877.
  • Publication of Selected Abstracts in Line with Renewed R13 Grant from NIDA Supporting ISAM Conferences, Managed Via ASAM

Training Committee

Dr. Shalini Arunogiri and Dr. Cor de Jong (Co-Chairs)


This will be accomplished through a number of activities that will be determined through a shared education and training strategy, including:

  • Training and education workshops and symposia at the annual ISAM Conference
  • Scoping activities to identify areas of training and education need internationally, through surveys of the ISAM global membership and consensus-based prioritization
  • Development of training and education modules or packages to be delivered in response to areas of need
  • Joint work in collaboration with international ISAM affiliate organisations to deliver training and education activities in response to local areas of need


Dr. Shalini Arunogiri (Australia)
Deputy Clinical Director at Turning Point (national addiction treatment and research centre)
Deputy Head and Senior Lecturer at the Department of Psychiatry at Central Clinical School, Monash University, Australia.
Chair of the RANZCP Binational Faculty of Addiction Psychiatry, for psychiatrists across Australia and New Zealand.



Dr. Cor de Jong (Netherlands)
Emeritus professor in addiction care, Radboud University, Nijmegen, Netherlands
Former scientific director, Nijmegen Institute for Scientist-Practitioner in Addictions – NISPA


Committee members